[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Injections in Denmark", "description": "Vaccine technique can be a rare cause of clots\n\nhttps://translate.google.com/translate?sl=da&tl=en&u=https://nyheder.tv2.dk/samfund/2021-03-22-ssi-anbefaler-ny-vaccineteknik-efter-sjaeldne-blodpropper\n\nState Serum Institute of Denmark, now recommends injection aspiration before injecting vaccine\n\nThis is a change in the recommendations\n\nBased on a precautionary principle\n\nNormally deltoid muscle does not have major vessels\n\nAspiration prolongs injection time so may be more painful\n\nThere is suspicion as to whether accidental injection of the vaccine into a blood vessel could play a role\n\nNo knowledge or data to support this suspicion\n\nNew recommendation only applies to covid vaccine\n\nIntravascular administration may lead to a systemic inflammatory reaction leading to blood clots\n\nDanish nursing council\n\nCovid-19 vaccines should be given with aspiration before injection\n\nhttps://sqd34kucpgoufz3qiuiswlotka--dsr-dk.translate.goog/politik-og-nyheder/nyhed/covid-19-vacciner-skal-gives-med-aspiration-foer-injektion\n\nAspiration is recommended for all approved covid-19 vaccines\n\nConsistent with the Danish Health and Medicines Authority's guidelines\n\nVaccination personnel should ensure that they are injected correctly into a muscle and not into the bloodstream\n\nPossible connection between the AstraZeneca vaccine and rare but serious side effects with blood clots and bleeding\n\nAnd the link to the updated instructions from the Danish Serum Institute\n\nhttps://www.ssi.dk/vaccinationer/injektionsteknik/intramuskulaer-injektion-beorn-og-voksne\n\nGoogle Translate:\n\nhttps://translate.google.com/translate?sl=da&tl=en&u=https://www.ssi.dk/vaccinationer/injektionsteknik/intramuskulaer-injektion-beorn-og-voksne\n\nDanish Nurse association\n\nhttps://dsr.dk/politik-og-nyheder/nyhed/covid-19-vacciner-skal-gives-med-aspiration-foer-injektion\n\nGoogle Translate:\n\nhttps://translate.google.com/translate?sl=da&tl=en&u=https://dsr.dk/politik-og-nyheder/nyhed/covid-19-vacciner-skal-gives-med-aspiration-foer-injektion\n\nDanish doctor complains about the way the vaccinations are being given which he thinks is incorrect, because aspiration is not being done\n\nhttps://sundhedspolitisktidsskrift.dk/nyheder/4614-myndighed-sadler-om-aendrer-anbefaling-om-vaccineteknik-efter-meldinger-om-farlige-bivirkninger.html\n\nGoogle Translate:\n\nhttps://translate.google.com/translate?hl=&sl=da&tl=en&u=https%3A%2F%2Fsundhedspolitisktidsskrift.dk%2Fnyheder%2F4614-myndighed-sadler-om-aendrer-anbefaling-om-vaccineteknik-efter-meldinger-om-farlige-bivirkninger.html\n\nWhen vaccinating, it is important to make sure that the vaccine does not go directly into the bloodstream. \n\nThe plunger should be pulled back slightly, if blood comes in find a new place \n\nUK and WHO guidelines\n\nhttps://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/147915/Green-Book-Chapter-4.pdf\n\nVaccines should not be given intravenously. \n\nIt is not necessary to aspirate the syringe after the needle is introduced into the muscle (WHO, 2004; Plotkin and Orenstein, 2004). \n\nPlotkin SA and Orenstein WA (eds) (2008) Vaccines, 5th edition. Philadelphia: WB Saunders Company. \n\nWorld Health Organization (2004) Immunization in practice: a guide for health workers. WHO. \n\nhttps://apps.who.int/iris/bitstream/handle/10665/193412/9789241549097_eng.pdf?sequence=1&isAllowed=y", "link": "https://www.youtube.com/watch?v=md8pJFbMVnk", "date_published": "2021-03-24 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Professor Tim Spector discussion", "description": "To learn more about ZOE and the ZOE COVID Study subscribe to their YouTube channel at https://www.youtube.com/zoe-health.\nFor more information on the ZOE COVID Study visit https://covid.joinzoe.com/  and to join the study, simply download the app from the Apple App Store: https://apps.apple.com/gb/app/covid-symptom-tracker/id1503529611 or Google Play Store: https://play.google.com/store/apps/details?id=com.joinzoe.covid_zoe .\nFind out more about ZOE's work in nutrition and the gut microbiome at https://joinzoe.com/our-science.", "link": "https://www.youtube.com/watch?v=zMi3A0suSMI", "date_published": "2021-03-24 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Good vaccine news in US", "description": "AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis\n\nhttps://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/astrazeneca-us-vaccine-trial-met-primary-endpoint.html\n\nhttps://clinicaltrials.gov/ct2/show/NCT04516746?term=NCT04516746&draw=2&rank=1\n\nInterim safety and efficacy analysis\n\nN =  32,449\n\n2:1 randomisation of vaccine to placebo\n\nAccruing 141 symptomatic cases of COVID-19\n\nStatistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19\n\n100% efficacy at preventing severe disease and hospitalisation\n\nVaccine efficacy was consistent across ethnicity and age\n\nAged 65 years and over, vaccine efficacy was 80%\n\nThe vaccine was well tolerated\n\nFavourable reactogenicity and overall safety\n\nIndependent data safety monitoring board (DSMB) identified no safety concerns\n\nDSMB conducted a specific review of thrombotic events, as well as cerebral venous sinus thrombosis \n\n(CVST) with the assistance of an independent neurologist\n\nDSMB found no increased risk of thrombosis or events characterised by thrombosis, n = 21,583, receiving at least one dose of the vaccine\n\nThe specific search for CVST found no events in this trial\n\n79% white/Caucasian\n\n8% black/African American\n\n4% native American \n\n4% Asian\n\n22% of participants were Hispanic.\n\nTwo doses administered, four week interval\n\nExtended interval of up to 12 weeks demonstrated greater efficacy\n\nSupported by immunogenicity data\n\nThis evidence suggests administration of the second dose with an interval \n\nLonger interval could further increase efficacy\n\nand accelerates the number of people who can receive their first dose\n\nStored, transported and handled at normal refrigerated conditions \n\n2-8 degrees Celsius or 36-46 degrees Fahrenheit, for at least six months\n\nCounter argument\n\nhttps://www.nih.gov/news-events/news-releases/niaid-statement-astrazeneca-vaccine\n\nConcerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial. \n\nAstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data. \n\nFood and Drug Administration and Centers for Disease Control and Prevention to decide.\n\nAfter thorough review of the data by independent advisory committees", "link": "https://www.youtube.com/watch?v=OBA9xTTAC8g", "date_published": "2021-03-23 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]